The relationship between frailty and social vulnerability: a systematic review
- PMID: 38432249
- DOI: 10.1016/S2666-7568(23)00263-5
The relationship between frailty and social vulnerability: a systematic review
Abstract
Both frailty (reduced physiological reserve) and social vulnerability (scarcity of adequate social connections, support, or interaction) become more common as people age and are associated with adverse consequences. Analyses of the relationships between these constructs can be limited by the wide range of measures used to assess them. In this systematic review, we synthesised 130 observational studies assessing the association between frailty and social vulnerability, the bidirectional longitudinal relationships between constructs, and their joint associations with adverse health outcomes. Frailty, across assessment type, was associated with increased loneliness and social isolation, perceived inadequacy of social support, and reduced social participation. Each of these social vulnerability components was also associated with more rapid progression of frailty and lower odds of improvement compared with the absence of that social vulnerability component (eg, more rapid frailty progression in people with social isolation vs those who were not socially isolated). Combinations of frailty and social vulnerability were associated with increased mortality, decline in physical function, and cognitive impairment. Clinical and public health measures targeting frailty or social vulnerability should, therefore, account for both frailty and social vulnerability.
Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests MKA reports research grants from GSK, Pfizer, Sanofi, Public Health Agency of Canada, COVID-19 Immunity Task Force, Canadian Institutes of Health Research (paid to the institution), past honoraria from Sanofi, past conference registration fees from GSK (part of a grant-funded project), and past honoraria for ad-hoc advisory activities from Sanofi, Pfizer, and Sequirus. MKA is also a voluntary member of Canada's National Advisory Committee on Immunization. All other authors declare no competing interests.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
